Latest news

Insights

How Pharma Companies Are Adapting to Market Disruption

Executive Summary Pharma companies are adapting to market disruption in 2026 by shifting from traditional, linear operating models to integrated,...
Insights

How Is AI Transforming Market Access and Commercial Decision-Making?

AI Transforming:Executive Summary AI is transforming market access and commercial decision-making in pharma by enabling data-driven, predictive, and continuously optimized...
Insights

How Are Biotech Firms Building Resilient Innovation Pipelines?

Executive Summary Biotech firms are building resilient innovation pipelines in 2026 by shifting from single-asset, high-risk models to diversified, data-driven,...
Clinical

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

IDEAYA Biosciences and Servier announced that their investigational combination therapy met the primary endpoint in a mid-to-late-stage clinical trial...
Clinical

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Revolution Medicines reported that its pan-RAS inhibitor enabled patients...
Clinical

Tepezza Sales Dip Slightly as Subcutaneous Formulation Shows Late-Stage Efficacy

Sales of Amgen’s thyroid eye disease (TED) treatment Tepezza...
Clinical

Sanofi’s Bispecific Stumbles in Eczema but Delivers Dual Wins in Respiratory Trials

Eczema "Sanofi has reported mixed mid-stage results for its bispecific nanobody lunsekimig—failing in atopic dermatitis while delivering encouraging outcomes...
Commercial

OrbiMed Announces $137M Series B Financing For Sidewinder

Three years after securing a series A round backed by OrbiMed in 2023, Sidewinder Therapeutics has raised additional capital...
Manufacturing

Vivtex Expands R&D and Workforce Following $2.1 Billion Novo Nordisk Partnership

Despite securing a partnership valued at up to $2.1 billion, Vivtex Therapeutics is continuing to prioritize internal research and...
Clinical

Insmed Halts Brinsupri Expansion After Second Mid-Stage Setback

Insmed has discontinued development of its drug Brinsupri in...
Regulatory

Louisiana Court Orders FDA to Update Mifepristone Safety Review Within Six Months

A federal court in Louisiana has instructed the U.S....
Regulatory

China approves Amgen and BeOne’s lung cancer medication Imdelltra

China’s drug regulator, the National Medical Products Administration, has approved a new lung cancer therapy developed by Amgen. The...
Commercial

Roche Commits $20 Million Upfront and Over $1 Billion in Milestones in C4 Therapeutics DAC Partnership

Roche has entered a new collaboration with C4 Therapeutics (C4T), agreeing to pay $20 million upfront and commit more...
Commercial

Roche Wagers $20M on C4T’s Antibody-Focused Protein Degraders

Roche has entered the emerging degrader-antibody conjugate (DAC) space alongside other major pharmaceutical players, striking a deal with C4...
Commercial

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

Regeneron Pharmaceuticals has entered the radiopharmaceutical sector through a...
Editorial Team -
Commercial

Boehringer signs $500 million deal with British biotech company to treat autoimmune illnesses orally

Boehringer Ingelheim has signed a preclinical program contract with...
Commercial

Care Management Program for Complex & Rare Conditions Launched by Accredo

Evernorth, a subsidiary of the healthcare company Cigna, has...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Insights

How Is AI Transforming Market Access and Commercial Decision-Making?

AI Transforming:Executive Summary AI is transforming market access and commercial...
Insights

How Are Biotech Firms Building Resilient Innovation Pipelines?

Executive Summary Biotech firms are building resilient innovation pipelines in...
Clinical

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

IDEAYA Biosciences and Servier announced that their investigational combination...
Commercial

Regeneron Partners with Telix in Radiopharmaceutical Collaboration Covering Up to Eight Cancer Programs

Regeneron Pharmaceuticals has entered the radiopharmaceutical sector through a...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

How Pharma Companies Are Adapting to Market Disruption

Executive Summary Pharma companies are adapting to market disruption in...
Editorial Team -
Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -
Insights

How Are Biotech Firms Building Resilient Innovation Pipelines?

Executive Summary Biotech firms are building resilient innovation pipelines in...
Editorial Team -